Reference : In vivo administration of a PKA type I inhibitor (Rp-8-Br-cAMPS) restores T-cell respons...
Scientific journals : Article
Human health sciences : Immunology & infectious disease
http://hdl.handle.net/2268/18769
In vivo administration of a PKA type I inhibitor (Rp-8-Br-cAMPS) restores T-cell responses in retrovirus-infected mice
English
Nayjib, Btissam mailto [Université de Liège - ULg > Doct. sc. bioméd. & pharma. (Bologne)]
Zeddou, Mustapha mailto [Université de Liège - ULg > Département des sciences cliniques > Rhumatologie >]
Drion, Pierre mailto [Université de Liège - ULg > Services généraux (Faculté de médecine vétérinaire) > Méth. expér. des anim. de labo et éthique en expér. animale >]
Boniver, Jacques mailto [Centre Hospitalier Universitaire de Liège - CHU > > Anatomie pathologique >]
Tasken, K. [University of Oslo > Biotechnology Centre of Oslo >]
Rahmouni, Souad mailto [Université de Liège - ULg > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén. >]
Moutschen, Michel mailto [Université de Liège - ULg > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén. >]
2008
Open Immunol journal
Bentham
1
20-24
Yes
International
1874-2262
1874-2262
[en] PKA Type I Inhibitor ; Retrovirus-Infected Mice ; T-Cell Responses
[en] Murine AIDS (MAIDS) is caused by infection with the murine leukemia retrovirus RadLV-Rs and is characterized by T-cell anergy and severe immunodeficiency with increased susceptibilty to several experimental opportunistic infections as observed in HIV infection. T cell anergy is associated with an increase of intracellular cAMP level, triggering a multistep pathway involving activation of PKA type I and resulting in inhibition of proximal TCR signaling. We have reviously demonstrated that blocking PKA type I using the selective inhibitor Rp-8-Br-cAMPS, restores T-cell function in vitro in MAIDS as well as in HIV infection. In the present report, we investigated the effect of parenteral administration of Rp-8-Br-cAMPS in mice with MAIDS. We show that the compound is not toxic and partially restores the ex vivo proliferative responses to anti-CD3 mAb, but that it has no effect on the lymphadenopathy and splenomegaly characterizing
the MAIDS syndrome.
Giga-Infection, Immunity and Inflammation
Researchers ; Professionals
http://hdl.handle.net/2268/18769
10.2174/1874226200801010020

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Rahmouni_OImmunJ.pdfNo commentaryAuthor preprint675.49 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.